Cargando…

Vitamin D and its receptor regulate lipopolysaccharide‐induced transforming growth factor‐β, angiotensinogen expression and podocytes apoptosis through the nuclear factor‐κB pathway

AIMS/INTRODUCTION: To investigate the effects of vitamin D and its receptor on cytokines expression and podocytes apoptosis. MATERIALS AND METHODS: Cultured mouse podocytes were pre‐incubated with vitamin D or transiently transfected with small interfering ribonucleic acid (RNA) to knock down the vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lijuan, Zhang, Pengyuan, Guan, Hongyu, Huang, Zhimin, He, Xiaoying, Wan, Xuesi, Xiao, Haipeng, Li, Yanbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009129/
https://www.ncbi.nlm.nih.gov/pubmed/27180929
http://dx.doi.org/10.1111/jdi.12505
_version_ 1782451476815151104
author Xu, Lijuan
Zhang, Pengyuan
Guan, Hongyu
Huang, Zhimin
He, Xiaoying
Wan, Xuesi
Xiao, Haipeng
Li, Yanbing
author_facet Xu, Lijuan
Zhang, Pengyuan
Guan, Hongyu
Huang, Zhimin
He, Xiaoying
Wan, Xuesi
Xiao, Haipeng
Li, Yanbing
author_sort Xu, Lijuan
collection PubMed
description AIMS/INTRODUCTION: To investigate the effects of vitamin D and its receptor on cytokines expression and podocytes apoptosis. MATERIALS AND METHODS: Cultured mouse podocytes were pre‐incubated with vitamin D or transiently transfected with small interfering ribonucleic acid (RNA) to knock down the vitamin D receptor. Lipopolysaccharide was used to mimic the inflammation status of diabetes. RESULTS: In a lipopolysaccharide‐induced state, expressions of transforming growth factor‐β, angiotensinogen and vascular endothelial growth factor were similarly increased. Transforming growth factor‐β and angiotensinogen levels originally elevated by lipopolysaccharide challenge were distinctly reduced after pre‐incubation with vitamin D. Whereas after vitamin D receptor small interfering (si)RNA transfection, the aforementioned cytokines had opposite changes as expected. However, neither vitamin D pretreatment nor vitamin D receptor siRNA transfection influenced the previously increased vascular endothelial growth factor expression at messenger RNA or protein levels. When pretreated with vitamin D, decreases were observed for phosphorylated inhibitor‐κB and the inhibitor kinase proteins. After siRNA transfection, those proteins levels were further elevated. The originally increased transforming growth factor‐β and angiotensinogen levels as a result of lipopolysaccharide stimulation were reduced at both the messenger RNA and protein levels after the specific inhibition of the nuclear factor‐κB pathway with pyrrolidine dithiocarbamate. The apoptosis rate of podocytes was decreased in a parallel manner after vitamin D pre‐incubation, and increased after siRNA transfection, which was also suppressed by pyrrolidine dithiocarbamate. CONCLUSIONS: Vitamin D and its receptor might be involved in the progression of diabetic nephropathy by regulating transforming growth factor‐β, angiotensinogen expression and apoptosis of podocytes. The processes are mediated through the signaling of nuclear factor‐κB pathway.
format Online
Article
Text
id pubmed-5009129
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-50091292016-09-12 Vitamin D and its receptor regulate lipopolysaccharide‐induced transforming growth factor‐β, angiotensinogen expression and podocytes apoptosis through the nuclear factor‐κB pathway Xu, Lijuan Zhang, Pengyuan Guan, Hongyu Huang, Zhimin He, Xiaoying Wan, Xuesi Xiao, Haipeng Li, Yanbing J Diabetes Investig Articles AIMS/INTRODUCTION: To investigate the effects of vitamin D and its receptor on cytokines expression and podocytes apoptosis. MATERIALS AND METHODS: Cultured mouse podocytes were pre‐incubated with vitamin D or transiently transfected with small interfering ribonucleic acid (RNA) to knock down the vitamin D receptor. Lipopolysaccharide was used to mimic the inflammation status of diabetes. RESULTS: In a lipopolysaccharide‐induced state, expressions of transforming growth factor‐β, angiotensinogen and vascular endothelial growth factor were similarly increased. Transforming growth factor‐β and angiotensinogen levels originally elevated by lipopolysaccharide challenge were distinctly reduced after pre‐incubation with vitamin D. Whereas after vitamin D receptor small interfering (si)RNA transfection, the aforementioned cytokines had opposite changes as expected. However, neither vitamin D pretreatment nor vitamin D receptor siRNA transfection influenced the previously increased vascular endothelial growth factor expression at messenger RNA or protein levels. When pretreated with vitamin D, decreases were observed for phosphorylated inhibitor‐κB and the inhibitor kinase proteins. After siRNA transfection, those proteins levels were further elevated. The originally increased transforming growth factor‐β and angiotensinogen levels as a result of lipopolysaccharide stimulation were reduced at both the messenger RNA and protein levels after the specific inhibition of the nuclear factor‐κB pathway with pyrrolidine dithiocarbamate. The apoptosis rate of podocytes was decreased in a parallel manner after vitamin D pre‐incubation, and increased after siRNA transfection, which was also suppressed by pyrrolidine dithiocarbamate. CONCLUSIONS: Vitamin D and its receptor might be involved in the progression of diabetic nephropathy by regulating transforming growth factor‐β, angiotensinogen expression and apoptosis of podocytes. The processes are mediated through the signaling of nuclear factor‐κB pathway. John Wiley and Sons Inc. 2016-04-01 2016-09 /pmc/articles/PMC5009129/ /pubmed/27180929 http://dx.doi.org/10.1111/jdi.12505 Text en © 2016 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Articles
Xu, Lijuan
Zhang, Pengyuan
Guan, Hongyu
Huang, Zhimin
He, Xiaoying
Wan, Xuesi
Xiao, Haipeng
Li, Yanbing
Vitamin D and its receptor regulate lipopolysaccharide‐induced transforming growth factor‐β, angiotensinogen expression and podocytes apoptosis through the nuclear factor‐κB pathway
title Vitamin D and its receptor regulate lipopolysaccharide‐induced transforming growth factor‐β, angiotensinogen expression and podocytes apoptosis through the nuclear factor‐κB pathway
title_full Vitamin D and its receptor regulate lipopolysaccharide‐induced transforming growth factor‐β, angiotensinogen expression and podocytes apoptosis through the nuclear factor‐κB pathway
title_fullStr Vitamin D and its receptor regulate lipopolysaccharide‐induced transforming growth factor‐β, angiotensinogen expression and podocytes apoptosis through the nuclear factor‐κB pathway
title_full_unstemmed Vitamin D and its receptor regulate lipopolysaccharide‐induced transforming growth factor‐β, angiotensinogen expression and podocytes apoptosis through the nuclear factor‐κB pathway
title_short Vitamin D and its receptor regulate lipopolysaccharide‐induced transforming growth factor‐β, angiotensinogen expression and podocytes apoptosis through the nuclear factor‐κB pathway
title_sort vitamin d and its receptor regulate lipopolysaccharide‐induced transforming growth factor‐β, angiotensinogen expression and podocytes apoptosis through the nuclear factor‐κb pathway
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009129/
https://www.ncbi.nlm.nih.gov/pubmed/27180929
http://dx.doi.org/10.1111/jdi.12505
work_keys_str_mv AT xulijuan vitamindanditsreceptorregulatelipopolysaccharideinducedtransforminggrowthfactorbangiotensinogenexpressionandpodocytesapoptosisthroughthenuclearfactorkbpathway
AT zhangpengyuan vitamindanditsreceptorregulatelipopolysaccharideinducedtransforminggrowthfactorbangiotensinogenexpressionandpodocytesapoptosisthroughthenuclearfactorkbpathway
AT guanhongyu vitamindanditsreceptorregulatelipopolysaccharideinducedtransforminggrowthfactorbangiotensinogenexpressionandpodocytesapoptosisthroughthenuclearfactorkbpathway
AT huangzhimin vitamindanditsreceptorregulatelipopolysaccharideinducedtransforminggrowthfactorbangiotensinogenexpressionandpodocytesapoptosisthroughthenuclearfactorkbpathway
AT hexiaoying vitamindanditsreceptorregulatelipopolysaccharideinducedtransforminggrowthfactorbangiotensinogenexpressionandpodocytesapoptosisthroughthenuclearfactorkbpathway
AT wanxuesi vitamindanditsreceptorregulatelipopolysaccharideinducedtransforminggrowthfactorbangiotensinogenexpressionandpodocytesapoptosisthroughthenuclearfactorkbpathway
AT xiaohaipeng vitamindanditsreceptorregulatelipopolysaccharideinducedtransforminggrowthfactorbangiotensinogenexpressionandpodocytesapoptosisthroughthenuclearfactorkbpathway
AT liyanbing vitamindanditsreceptorregulatelipopolysaccharideinducedtransforminggrowthfactorbangiotensinogenexpressionandpodocytesapoptosisthroughthenuclearfactorkbpathway